Axsome Therapeutics Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for AXS-05 for the Treatment of Alzheimer’s Di…

FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026 NEW YORK, Dec. 31, 2025 ...

Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 in Narcolepsy Supporting NDA Submission

New Drug Application (NDA) submission on track for January 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome ...
IEEE

Coupling Mechanism Analysis and Stabilization Improvement for Hybrid System With GFL and GFM Converter Under Grid Faults

Abstract: The dynamic coupling between grid-following (GFL) and grid-forming (GFM) converters, as well as their interaction with synchronous generators (SGs), may have a significant influence on the ...
2UrbanGirls on MSN

Gonadorelin: A peptide gateway into endocrine and reproductive research

Peptides have long attracted attention in the scientific community due to their structural simplicity yet vast range of ...
IEEE

A VSG-LFC Scheme for Power System With Renewable Energy Sources Under Hybrid Trigger Mechanism

Abstract: This paper investigates the frequency regulation problems of integrated renewable energy sources (RESs) power system under the non-ideal environment in open communication networks. Some ...
Psychology Today

First-of-Its-Kind AI Digital Biomarker for Chronic Stress

Stress is a part of everyday life. Chronic stress that persists over an extended period of time can lead to a higher risk of developing physical and mental health issues. Having a method to quantify ...